Keine Story von Evaluate Ltd. mehr verpassen.

Evaluate Ltd.

  • 27.03.2013 – 17:21

    Pharma in 2012: Boom or Bust?

    London And Boston (ots/PRNewswire) - EP Vantage(R) [ ], EvaluatePharma(R) [ ]'s award-winning editorial team, today released its "2012 Year in Review [ ]" report. Despite numerous ups and downs, the sector exited on a positive note, giving hope that 2013 might be the start of sustained recovery. According to the report, Biotech stocks stormed ahead with the NASDAQ ...